Reese Pharmaceutical

Researchers at Ohio State University Comprehensive Cancer Center evaluated data from nearly 11,000 patients who took an at-home FIT test. "A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study published in JAMA Network Open." Read the full article below. https://lnkd.in/gwGaZKtK

We're happy to announce that our product is now available at CVS! 🎉 This partnership allows us to bring Reese's ColoTest® to even more customers, making it easier than ever to access at-home FIT testing. Learn more about our initiative towards family health history awareness and the launch of ColoTest® into 7,000 CVS stores in our most recent blog. https://lnkd.in/gZX8GqzX

Testing is essential, and so is advocacy.   "One of the main barriers to FIT testing is awareness — or, rather, the lack thereof. Many people are simply unaware of the existence of the FIT test or underestimate its importance in cancer prevention."   In the recent Tennessean article, find out more about early screening and FIT tests. https://lnkd.in/e-S2DNv9

Fecal Immunochemical Tests (FIT) are one of many screening options available for colorectal cancer. Talk with your doctor about what test is best for you, and read more about your screening options 👉 https://lnkd.in/gtEa55u Thank you Polymedco for sponsoring this series💙

Reese's President, Jeffrey Reese, takes a closer look at FIT tests in his recent article with MedCity News! "The findings show that those who complete one or more fecal immunochemical test (FIT) screenings are associated with a 33% lower risk of death from colorectal cancer." With colorectal cancer being the leading cause of death in men under the age of 50 and second for women under the age of 50, it is clear that more education about various tests is needed to increase screening. #colorectalcancer #mycrchistory #FITtest #cancerawareness https://lnkd.in/gNquZmwq

We’re thrilled to share that our President, Jeffrey Reese, was recently featured in Crain's Cleveland Business Morning 10! In his insightful interview, Jeff discussed our innovative strides in at-home testing solutions. Here at Reese, we’re committed to making healthcare more accessible and convenient, starting with Reese’s ColoTest®. A huge thank you to Paige Bennett at Crain’s Cleveland for the spotlight! https://lnkd.in/gT7MatM6

Reese's ColoTest® is expanding into 1,189 Rite Aid stores nationwide. We are proud to make our OTC stool screening test more accessible by having our product on shelves at Rite Aid! About ColoTest®: ☑ Requires no lab testing ☑ Has no diet restrictions ☑ Easy-to-use test ☑At-home testing

We proudly announce the launch of our “Know Your CRC History” social media campaign. This campaign focuses on educating consumers on their family medical history and if their history involves colorectal cancer. "Dr. Rafferty says knowing family history is important because it can tell you if are above average risk for colorectal cancer. Average risk is no family history, no inflammatory bowel disease, no prior colorectal cancer or polyp on your own." #mycrchistory https://lnkd.in/gZVSdBsR

We are proud to be selected as the Home Healthcare Product Showcase winner at #NACDSTSE 2024. Thank you for the support and recognition and congratulations to all category winners!

This weekend, see Reese's ColoTest®at booth #1760. Inquire about our numerous private label OTC lines and branded items like the NEW Reese's ColoTest®. For more information or to set up an appointment contact your regional sales manager. Jordan Stone: Jordan@healthsourcemarketing.com Dave Radka: Dave@healthsourcemarketing.com